An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120

Kaleido Biosciences333 enrolled

Overview

This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").

Study Type

OBSERVATIONAL

Enrollment

333

Conditions

COVID-19

Interventions

KB109 + Self Supportive CareOTHER

KB109 is a novel glycan

Self Supportive Care (SSC) AloneOTHER

Self Supportive Care (SSC) Alone

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Have consented to participate over the telephone * Have been randomized in either the K031-120 or K032-120 study Exclusion Criteria: * Have withdrawn consent from K031-120 or K032-120

Locations (2)

HealthStar Research, LLC

Hot Springs, Arkansas, United States

Quad Clinical Research

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Proportion of patients with persistent COVID-19 symptoms for at least 12-weeks post-randomization in K031-120 or K032-120 study.

Time frame: 12-weeks from randomization in K031-120 or K032-120

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.